2024 年业绩略低于市场预期锦欣生殖公布2024 年业绩：收入28.1 亿元，同比+0.8%；经调整净利润4.2 亿元，同比-11.7%，略低于市场预期，主要受一次性奖励/补助减少、海外市场前期投入的影响。发展趋势24 年行业波动中IVF 业务依然保持稳定，期待25 年政策红利释放。收入端：24 年公司取卵周期数约2.84 万，同比-6.3%，部分受患者预期医保及生育补贴落地而延缓就医影响；但...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.